EBS (STOCKS)
Emergent Biosolutions, Inc.
$11.030000
-0.010000 (-0.09%)
Prev close: $11.040000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Joseph C. Papa
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $584.60M
- Employees
- 900
- P/E (TTM)
- 8.53
- P/B (TTM)
- 1.00
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
1
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$1.06 | $-0.12 | +1.1812 | +974.59% |
|
Jun 2025 (Q2)
|
$0.16 | $-0.49 | +0.6549 | +132.33% |
|
Mar 2025 (Q1)
|
$0.71 | $0.44 | +0.2656 | +59.77% |
|
Dec 2024 (Q4)
|
$0.05 | $-0.50 | +0.5500 | +110.00% |
Financial Statements
| Revenues | $788.90M |
| Benefits Costs and Expenses | $683.00M |
| Costs And Expenses | $683.00M |
| Nonoperating Income/Loss | -$12.60M |
| Operating Expenses | $992.40M |
| Selling, General, and Administrative Expenses | $195.80M |
| Research and Development | $50.20M |
| Other Operating Expenses | $746.40M |
| Operating Income/Loss | $118.50M |
| Income/Loss From Continuing Operations After Tax | $75.90M |
| Income/Loss From Continuing Operations Before Tax | $105.90M |
| Income Tax Expense/Benefit | $30.00M |
| Net Income/Loss | $75.90M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $75.90M |
| Net Income/Loss Available To Common Stockholders, Basic | $75.90M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.42 |
| Diluted Earnings Per Share | $1.32 |
| Basic Average Shares | 54,300,000 |
| Diluted Average Shares | 57,100,000 |
| Assets | $1.46B |
| Current Assets | $786.90M |
| Inventory | $356.30M |
| Other Current Assets | $430.60M |
| Noncurrent Assets | $674.10M |
| Fixed Assets | $209.80M |
| Intangible Assets | $452.70M |
| Other Non-current Assets | $11.60M |
| Liabilities | $878.50M |
| Current Liabilities | $136.50M |
| Accounts Payable | $57.40M |
| Wages | $36.60M |
| Other Current Liabilities | $42.50M |
| Noncurrent Liabilities | $742.00M |
| Long-term Debt | $693.10M |
| Other Non-current Liabilities | $48.90M |
| Equity | $582.50M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $582.50M |
| Liabilities And Equity | $1.46B |
| Net Cash Flow From Operating Activities | $13.00M |
| Net Cash Flow From Operating Activities, Continuing | $13.00M |
| Net Cash Flow From Investing Activities | $101.90M |
| Net Cash Flow From Investing Activities, Continuing | $101.90M |
| Net Cash Flow From Financing Activities | -$22.20M |
| Net Cash Flow From Financing Activities, Continuing | -$22.20M |
| Exchange Gains/Losses | $100.00K |
| Net Cash Flow | $92.80M |
| Net Cash Flow, Continuing | $92.70M |
| Comprehensive Income/Loss | $75.70M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $75.70M |
| Other Comprehensive Income/Loss | $75.70M |
| Other Comprehensive Income/Loss Attributable To Parent | -$200.00K |